These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 10677125)

  • 1. New treatments for multiple sclerosis.
    Kilpatrick TJ; Soilu-Hänninen M
    Aust N Z J Med; 1999 Dec; 29(6):801-10. PubMed ID: 10677125
    [No Abstract]   [Full Text] [Related]  

  • 2. Disease modification in multiple sclerosis.
    Sheerani M
    J Pak Med Assoc; 2003 Dec; 53(12):612-5. PubMed ID: 14765944
    [No Abstract]   [Full Text] [Related]  

  • 3. [Multiple sclerosis].
    Itoyama Y
    No To Shinkei; 2000 Dec; 52(12):1051-5. PubMed ID: 11193536
    [No Abstract]   [Full Text] [Related]  

  • 4. [Current methods of the multiple sclerosis treatment].
    Kovalenko PA; Shamanskiĭ SV; Baziĭ NI
    Voen Med Zh; 2001 Oct; 322(10):45-52. PubMed ID: 11764483
    [No Abstract]   [Full Text] [Related]  

  • 5. Current disease-modifying therapies in multiple sclerosis.
    Kieseier BC; Hartung HP
    Semin Neurol; 2003 Jun; 23(2):133-46. PubMed ID: 12894379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous immunoglobulin and multiple sclerosis.
    Achiron A; Miron S
    Clin Rev Allergy Immunol; 2005 Dec; 29(3):247-54. PubMed ID: 16391400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disease-modifying drugs for multiple sclerosis: a rapid and systematic review.
    Clegg A; Bryant J; Milne R
    Health Technol Assess; 2000; 4(9):i-iv, 1-101. PubMed ID: 10944743
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment of multiple sclerosis. The present and the future. Study Group on Diagnosis and Therapy of Multiple Sclerosis].
    Cazzato G; Antonello RM; Zorzon M; Torre P; Zivadinov R; Moretti R; Bragadin LM; De Masi R; Nasuelli D
    Recenti Prog Med; 1999 Oct; 90(10):538-44. PubMed ID: 10592740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Escalating immunotherapy of multiple sclerosis.Austrian-German- Swiss Multiple Sclerosis Therapy Consensus Group [MSTCG].
    Rieckmann P; Toyka KV
    Eur Neurol; 1999; 42(3):121-7. PubMed ID: 10529535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Causal therapy of multiple sclerosis].
    Pöhlau D; Rieks M; Postert T; Hoffmann V; Przuntek H
    Dtsch Med Wochenschr; 1996 Nov; 121(45):1407-14. PubMed ID: 8964231
    [No Abstract]   [Full Text] [Related]  

  • 11. [Multiple sclerosis. Current review of failed and discontinued clinical trials of drug treatment].
    Wiendl H; Neuhaus O; Kappos L; Hohlfeld R
    Nervenarzt; 2000 Aug; 71(8):597-610. PubMed ID: 10996910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The new era of multiple sclerosis therapy.
    Olsson T
    J Intern Med; 2014 Apr; 275(4):382-6. PubMed ID: 24433367
    [No Abstract]   [Full Text] [Related]  

  • 13. [Early immunotherapy in MS reduces the risk of later disability. The secondary progressive course is delayed, according to a study with virtual placebo].
    Tedeholm H; Skoog B; Hillert J; Runmarker B; Stawiarz L; Oluf A
    Lakartidningen; 2007 May 30-Jun 3; 104(22):1684-8. PubMed ID: 17601317
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of multiple sclerosis: recent trials and future perspectives.
    Noseworthy JH; Gold R; Hartung HP
    Curr Opin Neurol; 1999 Jun; 12(3):279-93. PubMed ID: 10499173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunosuppressive Treatments in Multiple Sclerosis. Proceedings of the European Charcot Foundation Symposium. Seville, Spain, 28-30 November 2002.
    J Neurol Sci; 2004 Aug; 223(1):1-93. PubMed ID: 15470812
    [No Abstract]   [Full Text] [Related]  

  • 16. [Diagnostics and drug therapy of multiple sclerosis].
    Suomen Neurologinen Yhdistys ry
    Duodecim; 2002; 118(13):1411-23. PubMed ID: 12239889
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunomodulation in multiple sclerosis: from immunosuppression to neuroprotection.
    Neuhaus O; Archelos JJ; Hartung HP
    Trends Pharmacol Sci; 2003 Mar; 24(3):131-8. PubMed ID: 12628358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of multiple sclerosis.
    Rudick RA; Cohen JA; Weinstock-Guttman B; Kinkel RP; Ransohoff RM
    N Engl J Med; 1997 Nov; 337(22):1604-11. PubMed ID: 9371858
    [No Abstract]   [Full Text] [Related]  

  • 19. [What's new in multiple sclerosis therapy?].
    Vaney C; Derfuss T
    Rev Med Suisse; 2013 Jan; 9(371):285-7. PubMed ID: 23451607
    [No Abstract]   [Full Text] [Related]  

  • 20. [Recent therapeutic strategy for multiple sclerosis].
    Itoyama Y
    Rinsho Shinkeigaku; 2001 Dec; 41(12):1214-7. PubMed ID: 12235841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.